• Advances in Leadless Cardiac Defibrillation and Resynchronization Therapy (CI-492)
• Advances in Leadless Cardiac Pacing (CI-262) Alternative Lead Placement in Congenital Heart Disease (CI-046)
• Appropriate, Inappropriate or Delayed ICD Shocks: Current Data (CI-524)
• Challenges in CIED Implantation: A Focus on Difficult Venous Access? Balloon or Extract? (CI-226)
• Challenges in CIED Surveillance with Remote Monitoring (CI-234)
• Clinical Trials in CIEDs (CI-523)
• Conduction System Pacing: A Primer to Build a Successful Program (CI-049)
• Conduction System Pacing: What is New? (CI-569)
• Debate: All Patients Requiring Ventricular Pacing Should Undergo Some Form of Conduction System Pacing (CI-380)
• Debate: ICDs are No Longer Indicated for Primary Prevention in Patients with NICM (CI-253)
• Difficult Device Tracings: Match Wits with the Pros (CI-316)
• Disparities or Differences in ICD/CRTD Utilization (CI-402)
• Ethical Dilemmas in Cardiac Implantable Electronic Device Therapy (CI-494)
• How Best to Sync in Cardiac Resynchronization Therapy: A Practical Guide (CI-348)
• Infections and Cardiac Implantable Electronic Devices (CI-180)
• Late-Breaking Clinical Trials: Late Breaking Science (LB-736)
• Lead Extraction: Avoiding and Managing Complications (CI-334)
• Lead Extraction: Predicting Complications, Dealing with Vegetations and Effects on the Tricuspid Valve (CI-545)
• Magnetic Resonance Imaging in CIEDS (CI-495)
• mHealth and AI in CIED Care (CI-110)
• Non-Responders in CRT: Prevention and Management (CI-060)
• Novel CIEDs and Algorithms (CI-525)
• Recorded Cases: Devices and Autonomics (RC-729)
• Risk Stratification and ICD Utilization in Challenging Cardiac Conditions (CI-401)
• Risk Stratification For Sudden Cardiac Death in Ischemic and Nonischemic Cardiomyopathy: More Than Just Ejection Fraction (CI-493)
• Sex and Gender in Cardiac Implantable Device Development (JS-427)
• Sex Differences in CIEDs and Arrhythmia Syndromes (CI-563)
• The Evolution of Pacing Induced Cardiomyopathy: Where are We Now? (CI-213)
• The Keys to Shaping and Growing a Successful Charity in the Modern World of EP (CI-511)

After watching a reasonable amount of Cardiovascular Implantable Electronic Devices (Heart Rhythm 2022), the learner should be able to:

• Identify and analyze the latest scientific advances and innovations in the field of heart rhythm disorders.
• Select appropriate, evidence-directed pharmacological and non-pharmacological therapies to achieve optimal outcomes for patients with heart rhythm disorders.
• Recognize alternative perspectives regarding areas of controversy for which scientific evidence is insufficient, controversial, inconclusive, or confusing.
• Utilize quality improvement measures, methods, and tools to foster systems-based improvements in heart rhythm care, outcome, and value.
• Analyze and improve processes related to inter-professional teams, care coordination, patient engagement, and communication to optimize the delivery of patient- and family-centered care.
• Assess the impact of regulatory and institutional policies, and societal and cultural norms, on safety, timeliness, equity (including diversity and inclusion), effectiveness, efficiency, patient-centered care, and value.
• Utilize improved communication methods to engage with patients and caregivers for increased shared decision-making in the treatment of heart rhythm disorders
• Evaluate the latest technology available for both professionals and consumers in the field of heart rhythm disorders.
• Recognize disparities in health care and describe strategies to reduce these disparities in patient care.
• Utilize shared decision-making resources in discussing monitoring and treatment of patients with heart rhythm disorders.
• Describe the latest cardiac device advisories and/or recalls and explain how to share this information with patients and caregivers.
• Explain the current and future trends in digital health that will impact the treatment of heart rhythm disorders.
• Describe best practices for managing a device clinic, an AF center, and/or a multidisciplinary electrophysiology practice.

Learning objectives specific to the session are listed at the individual session within Cardiovascular Implantable Electronic Devices (Heart Rhythm 2022).

Accreditation Statement
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians AMA Designation Statement
The Heart Rhythm Society designates this internet enduring activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM Maintenance of Certification (MOC) Statement 

Royal College of Physicians and Surgeons of Canada MOC Recognition Statement
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Other Credit Available
A Credit Certificate (for physicians) or Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:
·         American Academy of Family Physicians (AAFP) (for elective credit)
·         American Academy of Nurse Practitioners Certification Board (AANPCB)
·         American Academy of Physician Assistants (AAPA)
·         American Nurses Credentialing Center (ANCC)
·         American Osteopathic Association (AOA) (for Category 2 credit)
·         Committee on Accreditation of Continuing Medical Education (Canada)
·         European Board for Accreditation in Cardiology (EBAC)
·         European CME Credits (ECMEC)
·         German Chambers of Physicians
·         National Society of Genetic Counselors (for Category 2 credit)
·         Oman Medical Specialty Board
·         Qatar Council for Healthcare Practitioners
·         Royal College of Physicians and Surgeons of Canada (RCPSC)

Disclosure Policy

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.

Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.

ACCME Definition:

*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Examples of such organizations include:

• Advertising, marketing, or communication firms whose clients are ineligible companies
• Bio-medical startups that have begun a governmental regulatory approval process
• Compounding pharmacies that manufacture proprietary compounds
• Device manufacturers or distributors
• Diagnostic labs that sell proprietary products
• Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
• Manufacturers of health-related wearable products
• Pharmaceutical companies or distributors
• Pharmacy benefit managers
• Reagent manufacturers or sellers

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company within the 24 months prior to the disclosure.

The Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:

Fair Balance - that content is balanced among various options available for treatment and not biased toward a particular product or manufacturer.

Patient Treatment Recommendations - that patient treatment recommendations contained in the content are evidence-based, are appropriate for the target audience, and that the patient treatment recommendations contribute to overall improvement in patient care.

Scientific Validity - those scientific studies cited in the activity conform to standards accepted by the scientific community.

Learning Objectives - that the educational content supports the learning objectives of the activity, and that the objectives stated for performance-in-practice are actionable and measurable.
Omissions - that no seminal studies, data, or best evidence are missing

ACE (formerly CME) and CoP Certificates will be awarded and available to download and print following the completion of the course and the course evaluation. Should you have any questions regarding your certificate(s), please contact CME@HRSonline.org.